Literature DB >> 8887762

Neuropeptide Y-enhanced diuresis and natriuresis in anaesthetized rats is independent of renal blood flow reduction.

A Bischoff1, W Erdbrügger, J Smits, M C Michel.   

Abstract

1. Neuropeptide Y (NPY) has been reported to enhance diuresis and natriuresis in anaesthetized rats although it is a potent renal vasoconstrictor in vitro in vivo in several species. Therefore, we have investigated anaesthetized rats to see whether reduction in renal blood flow (RBF) and enhancement of diuresis and natriuresis can occur concomitantly, and how diuresis and natriuresis might be enhanced despite reduced RBF. 2. Systemic or intrarenal NPY infusion (0.03-3 micrograms kg-1 min-1) had only a small effect on mean arterial pressure (maximal increase 15-20 mmHg) and heart rate (maximal decrease 30 beats min-1) but dose-dependently reduced RBF (maximal peak reduction 3 ml min-1) Endogenous creatinine clearance was not significantly altered. 3. In anaesthetized rats systemic infusion of 1 or 3 micrograms kg-1 min-1 NPY enhanced urine formation and sodium and calcium excretion by a maximum of 110, 110 and 45%, respectively, but did not alter potassium excretion. Enhancement of diuresis was also detectable in conscious rats. 4. The diuretic and natriuretic effects of systemically infused NPY were at least partly maintained in rats with decapsulated kidneys and in rats where NPY-induced increase of renal perfusion pressure was excluded mechanically by an adjustable clamp placed on the abdominal aorta. 5. Intrarenal infusion of 0.3 or 1 microgram kg-1 min-1 NPY reduced RBF to a greater extent than systemic infusion (maximal peak reduction 4 ml min-1) but caused a smaller enhancement or even a reduction of urine formation and sodium excretion. 6. We conclude that systemic infusion of NPY reduces RBF by a direct effect on the renal vasculature. Systemic NPY infusion enhances urine formation and sodium and calcium excretion. This occurs independently (at least in part) of pressure natriuresis by formation and/or release of an extrarenal factor which might act on distal tubules and/or collecting ducts.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8887762      PMCID: PMC1160810          DOI: 10.1113/jphysiol.1996.sp021612

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  18 in total

1.  Release and vasoconstrictor effects of neuropeptide Y in relation to non-adrenergic sympathetic control of renal blood flow in the pig.

Authors:  J Pernow; J M Lundberg
Journal:  Acta Physiol Scand       Date:  1989-08

2.  Effects of neuropeptide-Y on renal function and its interaction with sympathetic stimulation in conscious dogs.

Authors:  P B Persson; H Ehmke; B Nafz; R Lang; E Hackenthal; R Nobiling; M S Dietrich; H R Kirchheim
Journal:  J Physiol       Date:  1991-12       Impact factor: 5.182

3.  Rapid desensitization of adrenaline- and neuropeptide Y-stimulated Ca2+ mobilization in HEL-cells.

Authors:  M C Michel
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

4.  Modulation of noradrenaline and neuropeptide Y (NPY) release in the pig kidney in vivo: involvement of alpha 2, NPY and angiotensin II receptors.

Authors:  J Pernow; J M Lundberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

5.  Chronic local infusion into the renal artery of unrestrained rats.

Authors:  J F Smits; C M Kasbergen; H van Essen; J C Kleinjans; H A Struyker-Boudier
Journal:  Am J Physiol       Date:  1983-02

6.  Neuropeptide Y inhibits renin release by a pertussis toxin-sensitive mechanism.

Authors:  E Hackenthal; K Aktories; K H Jakobs; R E Lang
Journal:  Am J Physiol       Date:  1987-03

7.  Neuropeptide Y: a novel renal peptide with vasoconstrictor and natriuretic activity.

Authors:  J M Allen; A E Raine; J G Ledingham; S R Bloom
Journal:  Clin Sci (Lond)       Date:  1985-04       Impact factor: 6.124

8.  Neuropeptide Y modulates the vascular response to periarterial nerve stimulation primarily by a postjunctional action in the isolated perfused rat kidney.

Authors:  W F Oellerich; K U Malik
Journal:  J Pharmacol Exp Ther       Date:  1993-09       Impact factor: 4.030

9.  Renovascular effects of neuropeptide-Y in the split hydronephrotic rat kidney: non-uniform pattern of vascular reactivity.

Authors:  M S Dietrich; M Fretschner; R Nobiling; P B Persson; M Steinhausen
Journal:  J Physiol       Date:  1991-12       Impact factor: 5.182

10.  The nerves of the juxtaglomerular apparatus of man and other mammals contain the potent peptide NPY.

Authors:  J Ballesta; J M Polak; J M Allen; S R Bloom
Journal:  Histochemistry       Date:  1984
View more
  3 in total

1.  Lysosphingolipid receptor-mediated diuresis and natriuresis in anaesthetized rats.

Authors:  A Bischoff; D Meyer Zu Heringdorf; K H Jakobs; M C Michel
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

2.  Sphingosine-1-phosphate reduces rat renal and mesenteric blood flow in vivo in a pertussis toxin-sensitive manner.

Authors:  A Bischoff; P Czyborra; D Meyer Zu Heringdorf; K H Jakobs; M C Michel
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

3.  Indomethacin differentiates the renal effects of sphingosine-1-phosphate and sphingosylphosphorylcholine.

Authors:  Claudia Czyborra; Angela Bischoff; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-03-07       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.